home / stock / casi / casi quote
Last: | $3.09 |
---|---|
Change Percent: | -0.96% |
Open: | $3.16 |
Close: | $3.09 |
High: | $3.23 |
Low: | $3.05 |
Volume: | 14,778 |
Last Trade Date Time: | 05/21/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.09 | $3.16 | $3.09 | $3.23 | $3.05 | 14,778 | 05-21-2024 |
$3.13 | $3.38 | $3.13 | $3.49 | $3.0731 | 14,889 | 05-20-2024 |
$3.3 | $3.2 | $3.3 | $3.305 | $3.17 | 16,779 | 05-17-2024 |
$3.245 | $3.54 | $3.245 | $3.54 | $3 | 16,981 | 05-16-2024 |
$3.27 | $3.47 | $3.27 | $3.54 | $3.2641 | 60,188 | 05-15-2024 |
$3.17 | $2.49 | $3.17 | $3.19 | $2.36 | 54,359 | 05-14-2024 |
$2.565 | $2.6 | $2.565 | $2.6 | $2.4 | 11,336 | 05-13-2024 |
$2.65 | $2.7577 | $2.65 | $2.7577 | $2.5395 | 6,650 | 05-10-2024 |
$2.623 | $2.67 | $2.623 | $2.7939 | $2.48 | 11,335 | 05-09-2024 |
$2.64 | $2.63 | $2.64 | $2.745 | $2.6111 | 2,988 | 05-08-2024 |
$2.61 | $2.69 | $2.61 | $2.795 | $2.59 | 2,409 | 05-07-2024 |
$2.75 | $2.83 | $2.75 | $2.835 | $2.75 | 9,268 | 05-06-2024 |
$2.795 | $2.75 | $2.795 | $2.85 | $2.66 | 9,536 | 05-03-2024 |
$2.68 | $2.39 | $2.68 | $2.77 | $2.36 | 14,627 | 05-02-2024 |
$2.39 | $2.37 | $2.39 | $2.43 | $2.3 | 5,733 | 05-01-2024 |
$2.354 | $2.26 | $2.354 | $2.43 | $2.26 | 5,734 | 04-30-2024 |
$2.34 | $2.37 | $2.34 | $2.3888 | $2.28 | 4,184 | 04-29-2024 |
$2.42 | $2.44 | $2.42 | $2.4465 | $2.36 | 3,669 | 04-26-2024 |
$2.3 | $2.49 | $2.3 | $2.61 | $2.22 | 27,765 | 04-25-2024 |
$2.44 | $2.51 | $2.44 | $2.58 | $2.44 | 9,117 | 04-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP) PR Newswire BEIJING , May 15, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company sp...
CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS PR Newswire BEIJING , May 14, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializin...
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS PR Newswire BEIJING , April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercia...